Atlas Trials

To Assess the Efficacy and Safety of the Cardio Formulation in Reducing Oxidized LDL

Clinical trial NCT04317287 · TERMINATED

Trial details

NCT number
NCT04317287
Sponsor
Supplement Formulators, Inc.
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Oxidized Low Density Lipoprotein
Start date
2019-12-10
Primary completion
2021-11-19
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.